Claire Mazumdar, a US-based biotech entrepreneur and CEO of a Nasdaqlisted firm, on Tuesday identified as the future successor to Kiran MazumdarShaw at Biocon, marking a key step in the company’s long-term leadership transition. Kiran Mazumdar-Shaw, founder and chairperson of Biocon, said she has formally charted a succession plan and chosen her niece Claire to.
